In HIV-infected patients psoriasis is often severe (1) and biologic therapy may therefore be needed. However, most dermatologists are cautious when using immunosuppressive agents in patients with HIV, as these agents may reactivate or induce infection in already immunocompromised patients (1). To date, only a few cases of HIV-infected psoriatic patients treated with biologics have been reported (2). We report here 10 cases of HIV patients treated for plaque psoriasis with biologic therapies in 6 psoriasis centres in Italy.

Biologic therapies in hiv-infected patients with psoriasi. An Italian experience / Bardazzi, Federico; Magnano, Michela; Campanati, Anna; Loconsole, Francesco; Carpentieri, Antonio; Potenza, Concetta; Bernardini, Nicoletta; Di Lernia, Vito; Carrera, Carlo; Raone, Beatrice; Patrizi, Annalisa; Loi, Camilla. - In: ACTA DERMATO-VENEREOLOGICA. - ISSN 0001-5555. - 97:8(2017), pp. 989-990. [10.2340/00015555-2698]

Biologic therapies in hiv-infected patients with psoriasi. An Italian experience

CARPENTIERI, Antonio;Potenza, Concetta;Bernardini, Nicoletta;
2017

Abstract

In HIV-infected patients psoriasis is often severe (1) and biologic therapy may therefore be needed. However, most dermatologists are cautious when using immunosuppressive agents in patients with HIV, as these agents may reactivate or induce infection in already immunocompromised patients (1). To date, only a few cases of HIV-infected psoriatic patients treated with biologics have been reported (2). We report here 10 cases of HIV patients treated for plaque psoriasis with biologic therapies in 6 psoriasis centres in Italy.
2017
hiv
01 Pubblicazione su rivista::01f Lettera, Nota
Biologic therapies in hiv-infected patients with psoriasi. An Italian experience / Bardazzi, Federico; Magnano, Michela; Campanati, Anna; Loconsole, Francesco; Carpentieri, Antonio; Potenza, Concetta; Bernardini, Nicoletta; Di Lernia, Vito; Carrera, Carlo; Raone, Beatrice; Patrizi, Annalisa; Loi, Camilla. - In: ACTA DERMATO-VENEREOLOGICA. - ISSN 0001-5555. - 97:8(2017), pp. 989-990. [10.2340/00015555-2698]
File allegati a questo prodotto
File Dimensione Formato  
Bardazzi_Biologic-therapies_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 231.67 kB
Formato Adobe PDF
231.67 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1023154
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 38
social impact